The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo

Beom Seok Kim, Hyomi Park, Seung Hwan Ko, Won Koo Lee, Ho Jeong Kwon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Sphingosine-1-phosphate (S1P) plays an important role in angiogenesis by stimulating DNA synthesis, chemotactic motility, and early blood vessel formation. Accordingly, the S1P signaling pathway is an attractive target for novel anti-angiogenic therapeutics. Here, we describe a small synthetic derivative of S1P that acts as an anti-angiogenic agent. We found that the S1P derivative NHOBTD [. N-((2. S,3. R)-3-hydroxy-1-morpholino-4-(3-octylphenyl)butan-2-yl)tetradecanamide] suppressed S1P-induced invasion and tube formation by human umbilical vein endothelial cells. NHOBTD also suppressed S1P signaling, as seen by destabilization of hypoxia inducible factor-1 alpha (HIF-1α) and secretion of VEGF, a transcriptional target of HIF-1α. Moreover, NHOBTD profoundly blocked endogenous neovascularization of the chick embryo chorioallantoic membrane, without rupturing any existing vessels. Together, these results demonstrate that NHOBTD is a new anti-angiogenic molecule that is capable of perturbing S1P signaling, and provides the basis for developing new anti-angiogenic drugs.

Original languageEnglish
Pages (from-to)189-193
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume413
Issue number2
DOIs
Publication statusPublished - 2011 Sep 23

Fingerprint

Derivatives
Hypoxia-Inducible Factor 1
Chorioallantoic Membrane
Morpholinos
Angiogenesis Inhibitors
Endothelial cells
Human Umbilical Vein Endothelial Cells
Blood vessels
Chick Embryo
sphingosine 1-phosphate
In Vitro Techniques
Vascular Endothelial Growth Factor A
Blood Vessels
Membranes
Molecules
DNA
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Kim, Beom Seok ; Park, Hyomi ; Ko, Seung Hwan ; Lee, Won Koo ; Kwon, Ho Jeong. / The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo. In: Biochemical and Biophysical Research Communications. 2011 ; Vol. 413, No. 2. pp. 189-193.
@article{dd29bd355adb40d0b1e8acc77c628594,
title = "The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo",
abstract = "Sphingosine-1-phosphate (S1P) plays an important role in angiogenesis by stimulating DNA synthesis, chemotactic motility, and early blood vessel formation. Accordingly, the S1P signaling pathway is an attractive target for novel anti-angiogenic therapeutics. Here, we describe a small synthetic derivative of S1P that acts as an anti-angiogenic agent. We found that the S1P derivative NHOBTD [. N-((2. S,3. R)-3-hydroxy-1-morpholino-4-(3-octylphenyl)butan-2-yl)tetradecanamide] suppressed S1P-induced invasion and tube formation by human umbilical vein endothelial cells. NHOBTD also suppressed S1P signaling, as seen by destabilization of hypoxia inducible factor-1 alpha (HIF-1α) and secretion of VEGF, a transcriptional target of HIF-1α. Moreover, NHOBTD profoundly blocked endogenous neovascularization of the chick embryo chorioallantoic membrane, without rupturing any existing vessels. Together, these results demonstrate that NHOBTD is a new anti-angiogenic molecule that is capable of perturbing S1P signaling, and provides the basis for developing new anti-angiogenic drugs.",
author = "Kim, {Beom Seok} and Hyomi Park and Ko, {Seung Hwan} and Lee, {Won Koo} and Kwon, {Ho Jeong}",
year = "2011",
month = "9",
day = "23",
doi = "10.1016/j.bbrc.2011.08.055",
language = "English",
volume = "413",
pages = "189--193",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo. / Kim, Beom Seok; Park, Hyomi; Ko, Seung Hwan; Lee, Won Koo; Kwon, Ho Jeong.

In: Biochemical and Biophysical Research Communications, Vol. 413, No. 2, 23.09.2011, p. 189-193.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo

AU - Kim, Beom Seok

AU - Park, Hyomi

AU - Ko, Seung Hwan

AU - Lee, Won Koo

AU - Kwon, Ho Jeong

PY - 2011/9/23

Y1 - 2011/9/23

N2 - Sphingosine-1-phosphate (S1P) plays an important role in angiogenesis by stimulating DNA synthesis, chemotactic motility, and early blood vessel formation. Accordingly, the S1P signaling pathway is an attractive target for novel anti-angiogenic therapeutics. Here, we describe a small synthetic derivative of S1P that acts as an anti-angiogenic agent. We found that the S1P derivative NHOBTD [. N-((2. S,3. R)-3-hydroxy-1-morpholino-4-(3-octylphenyl)butan-2-yl)tetradecanamide] suppressed S1P-induced invasion and tube formation by human umbilical vein endothelial cells. NHOBTD also suppressed S1P signaling, as seen by destabilization of hypoxia inducible factor-1 alpha (HIF-1α) and secretion of VEGF, a transcriptional target of HIF-1α. Moreover, NHOBTD profoundly blocked endogenous neovascularization of the chick embryo chorioallantoic membrane, without rupturing any existing vessels. Together, these results demonstrate that NHOBTD is a new anti-angiogenic molecule that is capable of perturbing S1P signaling, and provides the basis for developing new anti-angiogenic drugs.

AB - Sphingosine-1-phosphate (S1P) plays an important role in angiogenesis by stimulating DNA synthesis, chemotactic motility, and early blood vessel formation. Accordingly, the S1P signaling pathway is an attractive target for novel anti-angiogenic therapeutics. Here, we describe a small synthetic derivative of S1P that acts as an anti-angiogenic agent. We found that the S1P derivative NHOBTD [. N-((2. S,3. R)-3-hydroxy-1-morpholino-4-(3-octylphenyl)butan-2-yl)tetradecanamide] suppressed S1P-induced invasion and tube formation by human umbilical vein endothelial cells. NHOBTD also suppressed S1P signaling, as seen by destabilization of hypoxia inducible factor-1 alpha (HIF-1α) and secretion of VEGF, a transcriptional target of HIF-1α. Moreover, NHOBTD profoundly blocked endogenous neovascularization of the chick embryo chorioallantoic membrane, without rupturing any existing vessels. Together, these results demonstrate that NHOBTD is a new anti-angiogenic molecule that is capable of perturbing S1P signaling, and provides the basis for developing new anti-angiogenic drugs.

UR - http://www.scopus.com/inward/record.url?scp=80053104331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053104331&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2011.08.055

DO - 10.1016/j.bbrc.2011.08.055

M3 - Article

C2 - 21888894

AN - SCOPUS:80053104331

VL - 413

SP - 189

EP - 193

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -